P1138 EFFECTS OF SERUM 25(OH)D3 LEVELS ON TREATMENT RESPONSE TO TELAPREVIR/PEGYLATED-INTERFERON/RIBAVIRIN COMBINATION THERAPY FOR CHRONIC HEPATITIS C

2014 ◽  
Vol 60 (1) ◽  
pp. S461
Author(s):  
A. Nakagawa ◽  
M. Atsukawa ◽  
N. Shimada ◽  
A. Tsubota ◽  
H. Abe ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Combination Therapy ◽  
Treatment Response ◽  
Chronic Hepatitis C ◽  
Pegylated Interferon

scholarly journals Pegylated interferon-α2b and ribavirin combination therapy for pediatric patients with chronic hepatitis C

Kanzo ◽  
2008 ◽  
Vol 49 (8) ◽  
pp. 386-388 ◽  
Author(s):  
Ayano Inui ◽  
Haruki Komatsu ◽  
Tsuyoshi Sogo ◽  
Takuji Hashimoto ◽  
Tomoo Fujisawa
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Combination Therapy ◽  
Chronic Hepatitis C ◽  
Pediatric Patients ◽  
Pegylated Interferon ◽  
Interferon Α2b

scholarly journals Vitamin D-related gene polymorphism predict treatment response to pegylated interferon-based therapy in Thai chronic hepatitis C patients

2017 ◽  
Vol 17 (1) ◽  
Author(s):  
Kessarin Thanapirom ◽  
Sirinporn Suksawatamnuay ◽  
Wattana Sukeepaisarnjaroen ◽  
Pisit Tangkijvanich ◽  
Sombat Treeprasertsuk ◽  
...  
Keyword(s):  
Vitamin D ◽  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Gene Polymorphism ◽  
Treatment Response ◽  
Chronic Hepatitis C ◽  
Pegylated Interferon ◽  
Related Gene ◽  
Chronic Hepatitis C Patients ◽  
Predict Treatment Response
Sign in / Sign up

Export Citation Format

Share Document